Biomarin Pharmaceutical (BMRN) Q3 2025 Earnings

4AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
0.53
0.76
1
1.23

Details

Expected EPS
0.860823
Actual EPS
1.23
Surprise EPS
0.37
Surprise Percent
+42.89%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of 1.23 per share for Q3 2025.

0 Comments

Share your thoughts